Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivek Rajagopal

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Journal of the American Heart Association|October 24, 2019
Pacemaker Implantation and Dependency After Transcatheter Aortic Valve Replacement in the REPRISE III TrialChristopher U Meduri, Dean J Kereiakes, Vivek Rajagopal, et al.
JACC. Cardiovascular Interventions|June 11, 2025
3-Year Outcomes of Mitral Valve-in-Valve Therapy Using Balloon-Expandable Transcatheter Valves in the United StatesMackram F Eleid, Amar Krishnaswamy, Samir Kapadia, et al.
The New England Journal of Medicine|March 6, 2023
Five-Year Follow-up after Transcatheter Repair of Secondary Mitral RegurgitationGregg W Stone, William T Abraham, JoAnn Lindenfeld, et al.
JAMA Network Open|October 27, 2022
Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR: A Secondary Analysis of the REPRISE III Randomized Clinical TrialDavid G Rizik, Vivek Rajagopal, Raj R Makkar, et al.
The New England Journal of Medicine|October 4, 2018
Transcatheter Mitral-Valve Repair in Patients with Heart FailureGregg W Stone, JoAnn Lindenfeld, William T Abraham, et al.
European Heart Journal|May 17, 2021
A randomized evaluation of the TriGuard™ HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trialAlexandra J Lansky, Rajendra Makkar, Tamim Nazif, et al.
JACC. Cardiovascular Interventions|July 24, 2024
3-Year Outcomes From the Evolut Low Risk TAVR Bicuspid StudyFiras Zahr, Basel Ramlawi, Michael J Reardon, et al.
Journal of the American College of Cardiology|February 26, 2021
3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart FailureMichael J Mack, JoAnn Lindenfeld, William T Abraham, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 16, 2021
Outcomes of transcatheter mitral valve repair for secondary mitral regurgitation by severity of left ventricular dysfunctionStamatios Lerakis, Annapoorna S Kini, Federico M Asch, et al.
JAMA|January 4, 2018
Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical TrialTed E Feldman, Michael J Reardon, Vivek Rajagopal, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Journal of the American Heart Association|October 24, 2019
Pacemaker Implantation and Dependency After Transcatheter Aortic Valve Replacement in the REPRISE III TrialChristopher U Meduri, Dean J Kereiakes, Vivek Rajagopal, et al.
JACC. Cardiovascular Interventions|June 11, 2025
3-Year Outcomes of Mitral Valve-in-Valve Therapy Using Balloon-Expandable Transcatheter Valves in the United StatesMackram F Eleid, Amar Krishnaswamy, Samir Kapadia, et al.
The New England Journal of Medicine|March 6, 2023
Five-Year Follow-up after Transcatheter Repair of Secondary Mitral RegurgitationGregg W Stone, William T Abraham, JoAnn Lindenfeld, et al.
JAMA Network Open|October 27, 2022
Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR: A Secondary Analysis of the REPRISE III Randomized Clinical TrialDavid G Rizik, Vivek Rajagopal, Raj R Makkar, et al.
The New England Journal of Medicine|October 4, 2018
Transcatheter Mitral-Valve Repair in Patients with Heart FailureGregg W Stone, JoAnn Lindenfeld, William T Abraham, et al.
European Heart Journal|May 17, 2021
A randomized evaluation of the TriGuard™ HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trialAlexandra J Lansky, Rajendra Makkar, Tamim Nazif, et al.
JACC. Cardiovascular Interventions|July 24, 2024
3-Year Outcomes From the Evolut Low Risk TAVR Bicuspid StudyFiras Zahr, Basel Ramlawi, Michael J Reardon, et al.
Journal of the American College of Cardiology|February 26, 2021
3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart FailureMichael J Mack, JoAnn Lindenfeld, William T Abraham, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 16, 2021
Outcomes of transcatheter mitral valve repair for secondary mitral regurgitation by severity of left ventricular dysfunctionStamatios Lerakis, Annapoorna S Kini, Federico M Asch, et al.
JAMA|January 4, 2018
Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical TrialTed E Feldman, Michael J Reardon, Vivek Rajagopal, et al.
Pageof 7